Takeda Settles Diabetes Drug Patent Dispute
On Tuesday, the U.S. District Court for the Southern District of New York dismissed all claims and counterclaims between the two companies. Further information about the settlement was not disclosed.
Osaka, Japan-based Takeda sued Aurobindo in February for allegedly infringing its patents on Actoplus Met, a combination of pioglitazone hydrochloride and metformin hydrochloride.
The U.S. Food...
To view the full article, register now.